Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: srandl / Re:Lambert how will we know?

CPA's CFO's can correct me if I'm wrong, but in the case of a license deal for the MMP, UNLESS there is some level of royalties based on future products produced by the J's, it will show up on a receivables line once the agreement is made.

 

I believe that if PDS has licensed the MMP for a fixed price, even if it is to be paid iin installments, since no additional service or product is required from PDS to earn that money, it would be considered as a receivable and accounted for as such.

Share
New Message
Please login to post a reply